Psychotic disorders induced by antiepileptic drugs in people with epilepsy

Parkinson’s DiseasePsychosis and Schizophrenia

High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.

J Clin Psychopharmacol.

Mentzel TQ, Lieverse R, Bloemen O, Viechtbauer W, van Harten PN; Genetic Risk and Outcome of Psychosis (GROUP) Investigators

doi: 10.1097/

Further Publications NeurologyFurther Publications Psychiatry

Recent developments in drug-induced movement disorders: a mixed picture

Lancet Neurol.

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL

doi: 10.1016/S1474-4422(19)30152-8.

Epilepsy

Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy

Ann Neurol.

Glauser TA, Holland K, O'Brien VP, Keddache M, Martin LJ, Clark PO, Cnaan A, Dlugos D, Hirtz DG, Shinnar S, Grabowski G; Childhood Absence Epilepsy Study Group

doi: 10.1002/ana.24886.

RECOMMENDED

Epilepsy

Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy

JAMA Neurol.

Kim H, Faught E, Thurman DJ, Fishman J, Kalilani L

doi: 10.1001/jamaneurol.

Epilepsy

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J

doi: 10.1212/WNL.

Epilepsy

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Neurology

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J

doi: 10.1212/WNL.

Psychosis and Schizophrenia

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

JAMA Psychiatry.

Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA

doi: 10.1001/

Epilepsy

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis

Lancet Neurol.

Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, Overweg J, Sauma L, Specchio LM, Tennison M, Cardoso TMO, Shinnar S, Schmidt D, Geleijns K, Braun KPJ

doi: 10.1016/

Epilepsy

Therapeutic drug monitoring newer antiepileptic drugs: a randomised trial for dosage adjustment

Ann Neurol.

Aícua-Rapún I, André P, Rossetti AO, Ryvlin P, Hottinger AF, Decosterd LA, Buclin T, Novy J

doi: 10.1002/ana.25641.

Related content

High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.

Recent developments in drug-induced movement disorders: a mixed picture

Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy

Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis

Therapeutic drug monitoring newer antiepileptic drugs: a randomised trial for dosage adjustment